Compare · AGL vs QIPT
AGL vs QIPT
Side-by-side comparison of agilon health inc. (AGL) and Quipt Home Medical Corp. (QIPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and QIPT operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- AGL is the larger of the two at $6.03B, about 36.2x QIPT ($166.8M).
- Over the past year, AGL is down 72.9% and QIPT is up 71.1% - QIPT leads by 144.1 points.
- AGL has hit the wire 7 times in the past 4 weeks while QIPT has been quiet.
- AGL has more recent analyst coverage (25 ratings vs 6 for QIPT).
- Company
- agilon health inc.
- Quipt Home Medical Corp.
- Price
- $26.01-0.80%
- $3.65+0.00%
- Market cap
- $6.03B
- $166.8M
- 1M return
- +143.08%
- +2.24%
- 1Y return
- -72.94%
- +71.13%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 6
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Latest AGL
- SEC Form DEFA14A filed by agilon health inc.
- SEC Form DEF 14A filed by agilon health inc.
- SEC Form 4 filed by Zamore Denise
- SEC Form 4 filed by Venkatachaliah Girish
- SEC Form 4 filed by Gertsch Timothy
- SEC Form 4 filed by Shaker Benjamin
- agilon health Sets Date to Report First Quarter 2026 Financial Results
- SEC Form 4 filed by Schwaneke Jeffrey A.
- SEC Form 4 filed by Shaker Benjamin
- SEC Form 4 filed by Gertsch Timothy
Latest QIPT
- SEC Form 15-12G filed by Quipt Home Medical Corp.
- Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.
- Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Greenberg Mark Alan returned $1,589,418 worth of shares to the company (435,457 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Gamble Patrick Dennis returned $219,208 worth of shares to the company (60,057 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- President/CEO Crawford Gregory John returned $16,755,427 worth of shares to the company (4,590,528 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Carter Kevin A. returned $734,234 worth of shares to the company (201,160 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Bachelder David returned $80,869 worth of shares to the company (22,156 units at $3.65), closing all direct ownership in the company (SEC Form 4)